• Users Online: 176
  • Print this page
  • Email this page
Year : 2021  |  Volume : 4  |  Issue : 2  |  Page : 102-107

Adjuvant chemotherapy for stage II colon cancer: Whom to treat?

Department of Radiation Oncology, Action Cancer Hospital, New Delhi, India

Correspondence Address:
Dr. Deep S Pruthi
Department of Radiation Oncology, Action Cancer Hospital, A-4, Paschim Vihar, New Delhi
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jco.jco_20_21

Rights and Permissions

The treatment of choice in stage II colon cancer is surgery, which alone has shown a high cure rate (about 80%). The role of adjuvant chemotherapy is still a matter of debate. This clinical issue leads to the need for identifying patients who may benefit from postoperative chemotherapy based on their risk of recurrence. Patients with stage II colon cancer need to be stratified according to risk factors, which can be either clinical or pathological. In this review article, we analyzed various risk factors individually and try to quantify the relative contribution of each factor. We also analyzed various chemotherapy regimens and their duration as well.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded73    
    Comments [Add]    

Recommend this journal